Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.81 |
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.73 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.73 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.69 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.69 |
| ▸ | NQO2 | P16083 | 1/20 | 0.68 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.67 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.66 |
| ▸ | TUBB | P07437 | 1/20 | 0.66 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.66 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.66 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.66 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.66 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.66 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.66 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.66 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.66 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.66 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL700797 | 1.00 | RELA (0.81) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL14401251 | 1.00 | RELA (0.81) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL23158820 | 0.94 | RELA (0.84) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL700055 | 0.94 | RELA (0.84) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL31317665 | 0.94 | RELA (0.84) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL700056 | 0.94 | RELA (0.84) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL7592868 | 0.92 | RELA (0.70) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL7592867 | 0.92 | RELA (0.70) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL699631 | 0.90 | RELA (1.00) | RELANFE2L2CYP19A1CYP1A1CYP1A2 | |
| SCHEMBL699632 | 0.90 | RELA (1.00) | RELANFE2L2CYP19A1CYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105669391-A | Preparation method of 1-benzyloxy-2-[2-(3-methoxyphenyl)vinyl]benzene | 苏州诚和医药化学有限公司 | 2016-06-15 | — | — | CN | claimed |
| CN-116637102-B | Application of flavane compound in preparation of antitumor drugs | 北京中医药大学 | 2024-04-09 | — | — | CN | disclosed |
| WO-2021074275-A1 | EFFECTIVE PHOTOMODULATION OF LANTHANIDE (III) ION LUMINESCENCE IN THE VISIBLE OR NEAR-INFRARED RANGE | UNIVERSITE DE RENNES 1 (FR) | 2021-04-22 | — | — | WO | disclosed |
| US-9925153-B2 | Therapeutic agents for skin diseases and conditions | STC.UNM (US) | 2018-03-27 | — | — | US | disclosed |
| US-9868873-B2 | Photochromic security enabled ink for digital offset printing applications | XEROX CORPORATION (US) | 2018-01-16 | — | — | US | disclosed |
| CN-105669391-B | A kind of 1 benzyloxy 2 [2（3 methoxyphenyls）Vinyl] benzene preparation method | 苏州诚和医药化学有限公司 | 2018-01-09 | — | — | CN | disclosed |
| CN-105669391-B | A kind of 1 benzyloxy 2 [2（3 methoxyphenyls）Vinyl] benzene preparation method | 苏州诚和医药化学有限公司 | 2018-01-09 | — | — | CN | disclosed |
| CN-105541569-B | A kind of 1 benzyloxy 2 [2（3 methoxyphenyls）Vinyl] benzene synthetic method | 苏州诚和医药化学有限公司 | 2017-11-07 | — | — | CN | disclosed |
| CN-105218405-B | The synthesis technique of (R, S) 2 [[base of 5 (9 fluorenylmethyloxycarbonyl amino) dibenzo [A, D] cycloheptane 2] oxygen] acetic acid | 上海泰坦科技股份有限公司 | 2017-07-28 | — | — | CN | disclosed |
| US-20160287531-A1 | THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS | STC.UNM | 2016-10-06 | — | — | US | disclosed |
| EP-1591830-A2 | Reimageable medium | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1591831-A2 | Reimageable medium with light absorbing material | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| EP-1591829-A1 | Method for forming temporary image | Xerox Corporation (US) | 2005-11-02 | — | — | EP | disclosed |
| US-6392111-B1 | REACTING AROMATIC COMPOUND WITH OLEFIN | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2002-05-21 | — | — | US | disclosed |
| US-5759729-A | A DRY TONER COMPRISING A RESIN, PHOTOCHROMATIC SPIROPYRAN, -OXAZINE OR -THIOPYRAN DYE AND A CHARGE CONTROL AGENT;ELECTROGRAPHY; XEROGRAPHY | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | disclosed |
| US-5710420-A | Method for embedding and recovering machine-readable information | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | disclosed |
| US-5633109-A | Ink compositions with liposomes containing photochromic compounds | XEROX CORPORATION (US) | 1997-05-27 | — | — | US | disclosed |
| US-5593486-A | Photochromic hot melt ink compositions | XEROX CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5551973-A | LIQUID CRYSTAL GEL PHASE, MICROEMULSION PHASE | XEROX CORPORATION (US) | 1996-09-03 | — | — | US | disclosed |
| US-5314693-A | Hydroxystilbene compounds | KIORITZ CORPORATION (JP) | 1994-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160287531-A1 | THERAPEUTIC AGENTS FOR SKIN DISEASES AND CONDITIONS | CUTA, TSLP, ELANE | RELA 29/4885NFE2L2 696/4885CYP19A1 564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.